Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

SII makes strategic investment in IntegriMedical, India's First Needle-Free Injection System Technology

Written By Ruchika Sharma17 May 2024 4:09 PM IST

IntegriMedical's Needle-Free Injections System also known as N-FIS has received regulatory approvals from CDSCO, CE, MDSAP and is ISO 13485 certified.

ICMR invites EoI for joint development, commercialization of Salmonella vaccine

Written By Ruchika Sharma17 May 2024 2:59 PM IST

New Delhi: The Indian Council of Medical Research (ICMR) has issued a renewed call for Expression of Interest (EoI) from experienced Indian...

Indoco Remedies gets USFDA EIR for Patalganga facility

USFDA successfully completes inspection at Indoco API Kilo Lab facility, IAS division with no observations

Written By Ruchika Sharma17 May 2024 1:30 PM IST

Mumbai: Indoco Remedies Limited has announced that the United States Food and Drug Administration (USFDA) successfully completed inspection of...

Lupin bags USFDA nod for Midostaurin Capsules for Leukemia treatment

Written By Ruchika Sharma17 May 2024 12:20 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

USFDA grants accelerated approval for Bristol Myers Squibb CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Written By Ruchika Sharma16 May 2024 2:30 PM IST

Princeton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

USFDA approves Roche HPV self-collection solution in US

Written By Ruchika Sharma15 May 2024 1:05 PM IST

Basel: Roche has announced the FDA approval of its human papillomavirus (HPV) self-collection solution, one of the first available in the United...

Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma

Written By Ruchika Sharma14 May 2024 4:17 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca Pharma India, Vaayu Chest & Sleep Center collaborate to enhance respiratory care for severe asthma patients in Bengaluru

Written By Ruchika Sharma14 May 2024 12:37 PM IST

Bengaluru: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has partnered with Vaayu Chest & Sleep Center to elevate...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ to sell remaining 9.5 percent stake in Kenvue

Written By Ruchika Sharma14 May 2024 11:30 AM IST

Kenvue, the producer of Tylenol said on Monday that Johnson & Johnson will be selling off its remaining 9.5% stake in the company. This decision...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon, Medix join hands for commercialization of weight management drug Liraglutide in Mexico

Written By Ruchika Sharma13 May 2024 12:01 PM IST

Bengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, today announced the signing of a semi-exclusive distribution and...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Kite, Arcellx announce advances in Anito-Cel Multiple Myeloma Program

Written By Ruchika Sharma12 May 2024 10:00 AM IST

Redwood City: Kite, a Gilead Company, and Arcellx, Inc. have announced several key operational updates on their partnered anitocabtagene...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi, Novavax ink pact to co-commercialize COVID vaccine, develop novel flu-COVID combination vaccines

Written By Ruchika Sharma12 May 2024 10:00 AM IST

Paris: Sanofi has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US to develop...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok